Company Filing History:
Years Active: 2025
Title: Frederic Carly: Innovator in Gene Expression and Synthetic Biology
Introduction
Frederic Carly is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of synthetic biology, particularly in the area of gene expression. His innovative work has led to the development of a unique patent that enhances the regulation of gene expression.
Latest Patents
Frederic Carly holds a patent for an "Inducible promoter for gene expression and synthetic biology." This invention focuses on an inducible promoter that allows for improved and regulated gene expression, which is particularly useful in synthetic biology and metabolic engineering. The patent describes a nucleotide sequence that includes the regulatory regions of an erythritol- and erythrulose-inducible promoter in yeast. This advancement facilitates better gene expression and the production of gene products.
Career Highlights
Throughout his career, Frederic Carly has worked with esteemed organizations such as the Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement and the Université Libre de Bruxelles. His experience in these institutions has contributed to his expertise in the field of synthetic biology.
Collaborations
Frederic Carly has collaborated with notable colleagues, including Jean-Marc Nicaud and Marion Trassaert. These partnerships have further enriched his research and development efforts in gene expression.
Conclusion
Frederic Carly's contributions to synthetic biology and gene expression through his innovative patent demonstrate his commitment to advancing scientific knowledge. His work continues to influence the field and pave the way for future innovations.